# Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

> **NCT00946179** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 130 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza virus (split virion, inactivated) vaccine

## Key facts

- **NCT ID:** NCT00946179
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946179, "Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00946179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*